Skip to Content

M P9 (Pantoprazole Sodium Delayed Release 40 mg)

Pill with imprint M P9 is Yellow, Elliptical / Oval and has been identified as Pantoprazole Sodium Delayed Release 40 mg. It is supplied by Matrix Laboratories Limited.

Pantoprazole is used in the treatment of barrett's esophagus; gerd; dumping syndrome; duodenal ulcer; erosive esophagitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M P9

Pantoprazole Sodium Delayed Release

Imprint:
M P9
Strength:
40 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Matrix Laboratories Limited
Inactive Ingredients:
ammonia
ferrosoferric oxide
calcium stearate
crospovidone
hypromelloses
mannitol
methacrylic acid - ethyl acrylate copolymer (1:1) type a
povidone
propylene glycol
sodium carbonate
shellac
titanium dioxide
triethyl citrate
ferric oxide yellow
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0051 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide